Unleash the power of genomic data
Empowering precision in genomics
At Zetta Genomics our products and services are empowering the application of genomic data to improve health outcomes for millions of patients around the world.
We are pioneers in genomics with over a decade of experience – handling complex and large genomic data is at the heart of what we do. Born from the prestigious University of Cambridge and honed through our contributions to Genomics England’s landmark 100,000 Genomes Project, XetaBase leverages cutting-edge, real-world tested technology to deliver powerful genomic analysis solutions.
As a unified platform for both research and clinical applications, XetaBase enables us to collaborate with healthcare systems, life sciences companies, research institutions and global health-tech innovators, ensuring that the promise of precision medicine becomes a reality for all.
Native
technology
Scale
your data
Efficient data
management
An innovative
platform
An innovative platform
Our pioneering XetaBase platform is an all-in-one solution to load, normalise, aggregate, index, annotate, filter, visualise and enrich genomic data. It enables continual re-interpretation, unlocking valuable research and clinical insights.
Efficient data management
XetaBase optimises data management for cost-effective application of genomic data in both research and clinical settings.
Unmatched scalability
XetaBase’s scalability to 100,000s of genomes is unlocking the full potential of genomics, enhancing insights and outcomes on a population scale.
Real-time performance
XetaBase is a genomic-native technology, purpose built to meet the scale, speed and re-interpretation demands of massive and complex genomic data, enabling queries and analysis in seconds.

Zetta technologies
Zetta Genomics delivers genomic data management fit for the precision medicine age.
XetaBase is a uniquely genomic-native technology developed by world-leading researchers and data scientists. Specifically designed to deliver performance, scalability, and rich functionality – these three essential pillars are empowering bioinformaticians, clinicians and bench scientists to generate powerful genomic insights in both research and clinical settings.
XetaBase is revolutionising genomic analysis from the individual case level to whole populations at scale. Featuring the most advanced genomic variant database, XetaBase can index hundreds of thousands of whole genomes and trillions of variants. Our technology replaces slow and expensive legacy analysis methods which handle individual and flat VCF files. Our aggregated variant database can seamlessly scale as databases grow, enabling real-time execution of complex data queries to deliver results within seconds.

Zetta people
Zetta Genomics brings together a wealth of talent and diversity.
We simplify complex problems, holding ourselves to the highest standards as we work to make a positive impact on millions, perhaps billions, of lives around the world.
To achieve these powerful goals, we have the freedom to explore and try new and innovative approaches. We collaborate, support and respect each other, our partners and clients within a happy working environment. We ensure that everyone has a voice, is valued and is empowered to succeed. Simply, our mission is too important not to.
Zetta potential
We understand the importance of our
work and the potential of our technology.
Our technology is an enabler across virtually every research and clinical field in genomics, with the power to drive – and be driven by – advances in precision medicine. Our technologies help researchers and clinicians to make better, faster and more insightful decisions. Our ambition is to see XetaBase contribute to ever-more effective collaboration, inspire existing and new avenues of discovery – and ultimately change the lives of millions of people for the better. Zetta Genomics unleashes genomic data to realise the incredible power of precision medicine – and revolutionise healthcare for everyone.
partnership
Our partners
Zetta partners with like-minded organisations from both public and private sectors.




